Results 31 to 40 of about 796,231 (315)

Clinical efficacy and safety of subcutaneous rituximab in non-Hodgkin lymphoma: a systematic literature review and meta-analysis

open access: yesHematology, 2023
Objectives The role of subcutaneous (SC) rituximab in the efficacy and safety to non-Hodgkin lymphoma (NHL) is not clear enough. The purpose of this study was to conduct a systematic review and meta-analysis, to assess the efficacy and safety of ...
Tianyu Si   +3 more
doaj   +1 more source

Evaluation of subcutaneous proleukin (Interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants [PDF]

open access: yes, 2006
Background: ESPRIT, is a phase III, open-label, randomized, international clinical trial evaluating the effects of subcutaneous recombinant interleukin-2 (rIL-2) plus antiretroviral therapy (ART) versus ART alone on HIV-disease progression and death in ...
Tambussi, G.   +26 more
core   +1 more source

Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting [Corrigendum]

open access: yesPatient Preference and Adherence, 2021
Senbel E, Tropé S, Herman-Demars H, et al. Patient Prefer Adherence. 2021;15:751–760. Page 751, Abstract, Results section, the text “Switch to SC route increased the proportion of patients with remission or LDA from 22.8% to 52.9% and ...
Senbel E   +7 more
doaj  

Dystrophic calcifications and subcutaneous atrophy – rare complications of subcutaneous fat necrosis of the newborn

open access: yes, 2017
Introduction . Subcutaneous fat necrosis of the newborn is a rare form of panniculitis observed predominantly in neonates within the first weeks of life. In most cases subcutaneous lesions resolve spontaneously without complications.
Martyna Sławińska   +6 more
core   +1 more source

Subcutaneous Furosemide in Heart Failure

open access: yesJACC: Basic to Translational Science, 2018
Parenteral diuretics form the cornerstone of decongestion in heart failure. However, parenteral therapy routinely requires emergency room or inpatient care. A novel buffered furosemide formulation with neutral pH was developed to offer “hospital-strength”
Domenic A. Sica, MD   +6 more
doaj   +1 more source

A technique for subcutaneous abdominal adipose tissue biopsy via a nondiathermy method [PDF]

open access: yes, 2017
Adipose tissue biopsies offer tissue samples that, upon analysis, may provide insightful overviews of mechanisms relating to metabolism and disease. To obtain subcutaneous adipose tissue biopsies in the abdominal area, researchers and physicians use ...
Markella Chasioti   +11 more
core   +1 more source

The PPARy ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARy in the subcutaneous adipose tissue [PDF]

open access: yes, 2008
PPAR¿ is obligatory for fat mass generation and is thought to determine the amount of TAG stored per fat cell. We investigated whether ligand availability for PPAR¿ is rate limiting in fat mass generation and substrate metabolism.
Kersten, A.H.   +3 more
core   +1 more source

Subcutaneous phaeohyphomycosis: A rare case

open access: yesDermatology Reports, 2019
Phaeohyphomycosis is a rare fungal infection caused by melanized fungi which usually involve the skin and subcutaneous tissue. It is an infrequent cause of infection in human beings. Common clinical manifestations are subcutaneous cystic swellings, which
Zahruddin Ahmad   +6 more
doaj   +1 more source

Decoding the dynamic extracellular matrix in cancer—3D models and bioscaffolds rewire the rules of tumor progression

open access: yesFEBS Letters, EarlyView.
Cancer progression is regulated by the dynamic matrix code of the tumor microenvironment, which influences cellular behavior and disease development. Importantly, matrix remodeling in three‐dimensional cancer models more accurately reflects in vivo conditions compared to conventional two‐dimensional systems.
Sylvia Mangani   +3 more
wiley   +1 more source

Injectables and Depots to Prolong Drug Action of Proteins and Peptides

open access: yesPharmaceutics, 2020
Proteins and peptides have emerged in recent years to treat a wide range of multifaceted diseases such as cancer, diabetes and inflammation. The emergence of polypeptides has yielded advancements in the fields of biopharmaceutical production and ...
Nkiruka Ibeanu   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy